$PGEN
PRECIGEN, INC. Stock $pgen

$pgen Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000135609021000003 Filed on March 01, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$19.33M	$23.58M	$30.42M
YoY Change	13.71%	28.88%	-7.35%
Cost Of Revenue	$13.79M	$13.19M	$14.91M
YoY Change	-10.51%	-8.78%	-10.83%
Gross Profit	$5.540M	$10.40M	$15.51M
YoY Change	248.43%	170.83%	-3.78%
Gross Profit Margin	28.66%	44.1%	50.98%
Selling, General & Admin	$27.65M	$22.30M	$18.74M
YoY Change	5.74%	-9.87%	-12.77%
% of Gross Profit	499.1%	214.42%	120.83%
Research & Development	-$3.610M	$12.15M	$14.21M
YoY Change	-74.54%	-61.4%	-58.83%
% of Gross Profit	-65.16%	116.83%	91.62%
Depreciation & Amortization	$3.820M	$1.873M	$1.896M
YoY Change	-38.29%	-34.83%	-35.33%
% of Gross Profit	68.95%	18.01%	12.22%
Operating Expenses	$24.04M	$34.45M	$32.95M
YoY Change	100.67%	-51.93%	-55.11%
Operating Profit	-$35.17M	-$23.01M	-$11.83M
YoY Change	-48.83%	-33.7%	-45.0%
Interest Expense	-$4.160M	-$4.590M	-$4.070M
YoY Change	-5.67%	-202.66%	-193.39%
% of Operating Profit
Other Income/Expense, Net	-$310.0K	$10.00K	$70.00K
YoY Change	-103.88%	-100.26%	-123.33%
Pretax Income	-$920.0K	-$27.59M	-$15.83M
YoY Change	-97.51%	-43.77%	-51.02%
Income Tax	$50.00K	-$50.00K	-$120.0K
% Of Pretax Income
Net Earnings	-$41.66M	-$29.51M	-$43.35M
YoY Change	-75.38%	-44.98%	11.84%
Net Earnings / Revenue	-215.49%	-125.12%	-142.5%
Basic Earnings Per Share		-$0.18	-$0.26
Diluted Earnings Per Share	-$233.6K	-$0.18	-$0.26
COMMON SHARES
Basic Shares Outstanding	185.5M shares	165.5M shares	164.1M shares
Diluted Shares Outstanding		165.5M shares	164.1M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.1M	$113.1M	$133.0M
YoY Change	33.29%	6.7%	5.72%
Cash & Equivalents	$51.79M	$27.74M	$46.71M
Short-Term Investments	$48.30M	$85.40M	$86.30M
Other Short-Term Assets	$17.10M	$8.300M	$3.300M
YoY Change	-85.41%	-7.78%	-29.79%
Inventory	$11.40M	$10.30M	$12.70M
Prepaid Expenses
Receivables	$16.49M	$19.06M	$23.34M
Other Receivables	$232.0K	$300.0K	$400.0K
Total Short-Term Assets	$148.9M	$151.1M	$173.0M
YoY Change	-36.52%	-3.95%	-5.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$34.92M	$44.69M	$46.96M
YoY Change	-20.54%	-63.58%	-61.0%
Goodwill	$54.36M	$54.24M	$54.12M
YoY Change	0.45%	-63.34%	-63.9%
Intangibles	$65.40M	$65.02M	$64.76M
YoY Change	-4.32%	-39.32%	-42.45%
Long-Term Investments	$0.00	$337.0K	$859.0K
YoY Change	-100.0%	-98.07%	-95.25%
Other Assets	$1.603M	$1.497M	$1.341M
YoY Change	18.83%	-41.61%	-83.29%
Total Long-Term Assets	$165.6M	$185.1M	$188.7M
YoY Change	-25.09%	-58.65%	-60.02%
TOTAL ASSETS
Total Short-Term Assets	$148.9M	$151.1M	$173.0M
Total Long-Term Assets	$165.6M	$185.1M	$188.7M
Total Assets	$314.6M	$336.2M	$361.7M
YoY Change	-30.98%	-44.42%	-44.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.598M	$4.233M	$3.650M
YoY Change	-16.82%	-42.76%	-57.37%
Accrued Expenses	$20.30M	$21.50M	$21.60M
YoY Change	-33.0%	-27.85%	-15.29%
Deferred Revenue	$2.800M	$4.144M	$6.592M
YoY Change	-50.85%	-67.53%	-60.27%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$360.0K	$421.0K	$32.11M
YoY Change	-98.86%	-98.66%	6760.68%
Total Short-Term Liabilities	$42.13M	$30.66M	$64.10M
YoY Change	-65.73%	-62.59%	24.15%
LONG-TERM LIABILITIES
Long-Term Debt	$171.5M	$193.8M	$191.2M
YoY Change	-7.94%	5.31%	-10.01%
Other Long-Term Liabilities	$100.0K	$100.0K	$100.0K
YoY Change		-54.75%	-54.95%
Total Long-Term Liabilities	$171.6M	$193.9M	$191.3M
YoY Change	-7.89%	5.24%	-10.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.13M	$30.66M	$64.10M
Total Long-Term Liabilities	$171.6M	$193.9M	$191.3M
Total Liabilities	$247.4M	$277.6M	$312.2M
YoY Change	-35.58%	-26.26%	-16.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.823B	-$1.782B	-$1.752B
YoY Change	10.32%	20.09%	22.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$67.17M	$58.55M	$49.54M
YoY Change
Total Liabilities & Shareholders Equity	$314.6M	$336.2M	$361.7M
YoY Change	-30.98%	-44.42%	-44.79%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	-$41.66M	-$29.51M	-$43.35M
YoY Change	-75.38%	-44.98%	11.84%
Depreciation, Depletion And Amortization	$3.820M	$1.873M	$1.896M
YoY Change	-38.29%	-34.83%	-35.33%
Cash From Operating Activities	-$16.47M	-$19.00M	-$13.81M
YoY Change	-48.76%	-30.02%	-58.67%
INVESTING ACTIVITIES
Capital Expenditures	-$1.470M	-$1.030M	-$1.880M
YoY Change	-68.59%	-86.76%	-86.47%
Acquisitions
YoY Change
Other Investing Activities	$41.66M	$1.200M	$25.85M
YoY Change	-29.62%	-94.43%	-2387.61%
Cash From Investing Activities	$40.19M	$180.0K	$23.96M
YoY Change	-26.27%	-98.69%	-259.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-70.00K	-110.0K	-1.260M
YoY Change	-105.83%	-320.0%	3050.0%
NET CHANGE
Cash From Operating Activities	-16.47M	-19.00M	-13.81M
Cash From Investing Activities	40.19M	180.0K	23.96M
Cash From Financing Activities	-70.00K	-110.0K	-1.260M
Net Change In Cash	23.65M	-18.93M	8.890M
YoY Change	0.34%	42.01%	-118.34%
FREE CASH FLOW
Cash From Operating Activities	-$16.47M	-$19.00M	-$13.81M
Capital Expenditures	-$1.470M	-$1.030M	-$1.880M
Free Cash Flow	-$15.00M	-$17.97M	-$11.93M
YoY Change	-45.38%	-7.23%	-38.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001356090
CY2017	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201409Member
CY2018Q3	pgen	Share Lending Agreement Length Of Time For Shares To Be Returned Upon Termination ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination	P5D
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-36042
CY2020	dei	Entity Registrant Name EntityRegistrantName	PRECIGEN, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0084895
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	20374 Seneca Meadows Parkway
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown,
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
CY2020	dei	City Area Code CityAreaCode	301
CY2020	dei	Local Phone Number LocalPhoneNumber	556-9900
CY2020	dei	Security12b Title Security12bTitle	Common Stock, No Par Value
CY2020	dei	Trading Symbol TradingSymbol	PGEN
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	435100000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	205661239	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51792000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65793000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	48325000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	9260000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4825000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	11359000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5201000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16487000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20650000	USD
CY2020Q4	pgen	Related Party Receivable Allowancefor Credit Loss Current RelatedPartyReceivableAllowanceforCreditLossCurrent	1509000	USD
CY2019Q4	pgen	Related Party Receivable Allowancefor Credit Loss Current RelatedPartyReceivableAllowanceforCreditLossCurrent	2312000	USD
CY2020Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	19000	USD
CY2019Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	600000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3689000	USD
CY2019Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2942000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	232000	USD
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2030000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	16097000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7192000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5827000	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	9853000	USD
CY2019Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	111444000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	148948000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9353000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	234643000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34924000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43952000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	65396000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	68346000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	54363000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	54119000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1461000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11803000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1603000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1349000	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	40090000	USD
CY2020Q4	us-gaap	Assets Assets	314587000	USD
CY2019Q4	us-gaap	Assets Assets	455763000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4598000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5528000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8097000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13198000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9549000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11674000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2800000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5697000	USD
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2019Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1922000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	360000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	31670000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2657000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2634000	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	19000	USD
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	51000	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	14047000	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	50538000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42127000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	122912000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	171522000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	186321000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23023000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	48136000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7744000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10119000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2897000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2834000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	100000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	13730000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	247413000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	384052000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	187663207	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	187663207	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163274880	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163274880	shares
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1886567000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	455763000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-66748000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1752048000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1823390000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1652869000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3997000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27468000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	67174000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	71711000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	314587000	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-153582000	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-134219000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-170521000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-323916000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-514706000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1592000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5370000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-170521000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-322324000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-509336000	USD
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-103773000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-168742000	USD
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-375117000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-66748000	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-153582000	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-134219000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-170521000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-322324000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-509336000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.62
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-1.09
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-2.90
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.40
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-1.00
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-1.03
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.02
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.09
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.93
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	167065539	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	154138774	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	129521731	shares
CY2020	us-gaap	Profit Loss ProfitLoss	-170521000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-323916000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-514706000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	68000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-59000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4502000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1087000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-13073000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-26957000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-139056000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-322761000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-527838000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1581000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-5548000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-139056000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-321180000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-522290000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	546545000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36296000	USD
CY2018	pgen	Stock Issued During Period Value Restricted Stock Awards Vestedand Stock Optionsand Warrants Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedandStockOptionsandWarrantsExercised	2336000	USD
CY2018	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10695000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	87990000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	36868000	USD
CY2018	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	159323000	USD
CY2018	pgen	Adjustmentsfornoncontrollinginterests Adjustmentsfornoncontrollinginterests	0	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-514706000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13132000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	378722000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	378722000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18950000	USD
CY2019	pgen	Stock Issued During Period Value Restricted Stock Awards Vestedand Stock Optionsand Warrants Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedandStockOptionsandWarrantsExercised	313000	USD
CY2019	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	1102000	USD
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10446000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6611000	USD
CY2019	pgen	Adjustmentsfornoncontrollinginterests Adjustmentsfornoncontrollinginterests	0	USD
CY2019	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	21672000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-323916000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1155000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71711000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-170521000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-323916000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-514706000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17516000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24896000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33112000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4442000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3071000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-20928000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9635000	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	87862000	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	13326000	USD
CY2019	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	32627000	USD
CY2018	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	60504000	USD
CY2020	pgen	Disposal Group Including Discontinued Operation Gain Losson Disposal DisposalGroupIncludingDiscontinuedOperationGainLossonDisposal	672000	USD
CY2019	pgen	Disposal Group Including Discontinued Operation Gain Losson Disposal DisposalGroupIncludingDiscontinuedOperationGainLossonDisposal	0	USD
CY2018	pgen	Disposal Group Including Discontinued Operation Gain Losson Disposal DisposalGroupIncludingDiscontinuedOperationGainLossonDisposal	0	USD
CY2020	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-26957000	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	0	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	0	USD
CY2020	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2019	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2018	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	236748000	USD
CY2020	pgen	Gain Loss Related To Noncash Litigation Settlement GainLossRelatedToNoncashLitigationSettlement	-11436000	USD
CY2019	pgen	Gain Loss Related To Noncash Litigation Settlement GainLossRelatedToNoncashLitigationSettlement	0	USD
CY2018	pgen	Gain Loss Related To Noncash Litigation Settlement GainLossRelatedToNoncashLitigationSettlement	0	USD
CY2020	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	-106000	USD
CY2019	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	7833000	USD
CY2018	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	-30200000	USD
CY2020	pgen	Noncash Dividend Income NoncashDividendIncome	0	USD
CY2019	pgen	Noncash Dividend Income NoncashDividendIncome	48000	USD
CY2018	pgen	Noncash Dividend Income NoncashDividendIncome	14841000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	699000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1005000	USD
CY2018	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	771000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1176000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6730000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11608000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	18366000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	18950000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	36296000	USD
CY2020	pgen	Shares Issued During Period Value Issued For Services Expense SharesIssuedDuringPeriodValueIssuedForServicesExpense	1006000	USD
CY2019	pgen	Shares Issued During Period Value Issued For Services Expense SharesIssuedDuringPeriodValueIssuedForServicesExpense	10446000	USD
CY2018	pgen	Shares Issued During Period Value Issued For Services Expense SharesIssuedDuringPeriodValueIssuedForServicesExpense	10695000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	899000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3242000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1779000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10587000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2511000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21278000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9459000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4378000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-156000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3674000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-226000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-837000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1093000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2214000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	262000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2698000	USD
CY2020	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-258000	USD
CY2019	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-967000	USD
CY2018	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-11003000	USD
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1853000	USD
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	656000	USD
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	542000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4100000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	478000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	812000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2262000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1006000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	142000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-333000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-652000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1097000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-5349000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4680000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-789000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5186000	USD
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4385000	USD
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-2682000	USD
CY2019	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-5516000	USD
CY2018	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	356000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21045000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	7423000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-38578000	USD
CY2020	pgen	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-887000	USD
CY2019	pgen	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-995000	USD
CY2018	pgen	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-33000	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	45000	USD
CY2018	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-52000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-585000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	281000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77021000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-135927000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-124240000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	171360000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	55073000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	178681000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	133000000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	166495000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	65975000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	23456000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	217000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	920000	USD
CY2020	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	USD
CY2019	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	3713000	USD
CY2018	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	16582000	USD
CY2020	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2019	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	7244000	USD
CY2018	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	125000	USD
CY2018	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2598000	USD
CY2020	pgen	Cash Inflows Outflows In Asset Acquisition CashInflowsOutflowsInAssetAcquisition	0	USD
CY2019	pgen	Cash Inflows Outflows In Asset Acquisition CashInflowsOutflowsInAssetAcquisition	0	USD
CY2018	pgen	Cash Inflows Outflows In Asset Acquisition CashInflowsOutflowsInAssetAcquisition	15500000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7527000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37883000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41587000	USD
CY2020	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	6484000	USD
CY2019	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	688000	USD
CY2018	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	2267000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	64240000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2018	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2020	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2942000	USD
CY2019	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2018	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27779000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	86851000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151213000	USD
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	35000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2020	pgen	Proceedsfrom Issuanceof Common Stockand Warrants Net ProceedsfromIssuanceofCommonStockandWarrantsNet	0	USD
CY2019	pgen	Proceedsfrom Issuanceof Common Stockand Warrants Net ProceedsfromIssuanceofCommonStockandWarrantsNet	6611000	USD
CY2018	pgen	Proceedsfrom Issuanceof Common Stockand Warrants Net ProceedsfromIssuanceofCommonStockandWarrantsNet	87990000	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10005000	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	11757000	USD
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4561000	USD
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11927000	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10301000	USD
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4328000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	376000	USD
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	219859000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	490000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	618000	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	623000	USD
CY2020	pgen	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	117000	USD
CY2019	pgen	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	313000	USD
CY2018	pgen	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	2336000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32705000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8138000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	309795000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	353000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-810000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16184000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41748000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34637000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68434000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110182000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75545000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52250000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68434000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110182000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7202000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3751000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	3868000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	48000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	50000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	216000	USD
CY2020	pgen	Stock Received As Consideration For Collaboration Agreements StockReceivedAsConsiderationForCollaborationAgreements	0	USD
CY2019	pgen	Stock Received As Consideration For Collaboration Agreements StockReceivedAsConsiderationForCollaborationAgreements	4530000	USD
CY2018	pgen	Stock Received As Consideration For Collaboration Agreements StockReceivedAsConsiderationForCollaborationAgreements	0	USD
CY2020	pgen	Stock Issued Intangible Assets StockIssuedIntangibleAssets	0	USD
CY2019	pgen	Stock Issued Intangible Assets StockIssuedIntangibleAssets	0	USD
CY2018	pgen	Stock Issued Intangible Assets StockIssuedIntangibleAssets	159323000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	56827000	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2018	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020	pgen	Stock Issued Settlement Agreement StockIssuedSettlementAgreement	18103000	USD
CY2019	pgen	Stock Issued Settlement Agreement StockIssuedSettlementAgreement	0	USD
CY2018	pgen	Stock Issued Settlement Agreement StockIssuedSettlementAgreement	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	30000000	USD
CY2020	pgen	Accrued Compensation Paidin Equity Awards AccruedCompensationPaidinEquityAwards	5100000	USD
CY2019	pgen	Accrued Compensation Paidin Equity Awards AccruedCompensationPaidinEquityAwards	1102000	USD
CY2018	pgen	Accrued Compensation Paidin Equity Awards AccruedCompensationPaidinEquityAwards	0	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	277000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	694000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2267000	USD
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2019	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2018	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	234000	USD
CY2020	pgen	Sale Of Assets Included In Receivables SaleOfAssetsIncludedInReceivables	4227000	USD
CY2019	pgen	Sale Of Assets Included In Receivables SaleOfAssetsIncludedInReceivables	0	USD
CY2018	pgen	Sale Of Assets Included In Receivables SaleOfAssetsIncludedInReceivables	0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51792000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65793000	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	2223000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	458000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	418000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52250000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68434000	USD
CY2019	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-2648000	USD
CY2019Q4	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	21587000	USD
CY2019Q4	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	7348000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-170521000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1823390000	USD
CY2020	pgen	Collaboration Agreement Termination Notice Period CollaborationAgreementTerminationNoticePeriod	P90D
CY2020Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	12054000	USD
CY2019Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	14664000	USD
CY2020	pgen	Highly Liquid Investment Maximum Maturity Period HighlyLiquidInvestmentMaximumMaturityPeriod	P3M
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	30164000	USD
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	47238000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company's mix of fixed and variable rate securities holdings, the Company's investment portfolio is susceptible to changes in interest rates. As of December 31, 2020, gross unrealized losses on the Company's short-term investments were not material. From time to time, the Company may liquidate some or all of its investments to fund operational needs or other activities, such as capital expenditures or business acquisitions, or distribute its equity securities to shareholders as a stock dividend. Depending on which investments the Company liquidates to fund these activities, the Company could recognize a portion, or all, of the gross unrealized losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade and related party receivables. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs ongoing credit evaluations of its customers but generally does not require collateral to support accounts receivable.</span></div>
CY2020Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	0	USD
CY2019Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	1461000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	48312000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25823000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	53833000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2800000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5697000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23023000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	48136000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25823000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	53833000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	14000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48325000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9253000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	7000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	9260000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	48325000	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	9260000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	11359000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	16097000	USD
CY2020Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	9844000	USD
CY2019Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	9814000	USD
CY2020Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	12088000	USD
CY2019Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11765000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34924000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43952000	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1228000	USD
CY2019Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1025000	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	31150000	USD
CY2019Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	33707000	USD
CY2020Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6260000	USD
CY2019Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6607000	USD
CY2020Q4	pgen	Breedingand Production Animals Gross BreedingandProductionAnimalsGross	868000	USD
CY2019Q4	pgen	Breedingand Production Animals Gross BreedingandProductionAnimalsGross	5191000	USD
CY2020Q4	pgen	Computer Hardwareand Software ComputerHardwareandSoftware	5684000	USD
CY2019Q4	pgen	Computer Hardwareand Software ComputerHardwareandSoftware	6877000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2754000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5229000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	69876000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80215000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34952000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36263000	USD
CY2019	us-gaap	Depreciation Depreciation	8222000	USD
CY2018	us-gaap	Depreciation Depreciation	8946000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	920000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	448000	USD
CY2019Q3	pgen	Number Of Reporting Units Closed NumberOfReportingUnitsClosed	2	reporting_unit
CY2020	us-gaap	Depreciation Depreciation	7449000	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	43643000	USD
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	43643000	USD
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	178000	USD
CY2019Q3	pgen	Number Of Reporting Units Closed NumberOfReportingUnitsClosed	2	reporting_unit
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	113677000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	48281000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65396000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	107259000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	38913000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68346000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7593000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7920000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11666000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7704000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6908000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5742000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5432000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5419000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	34191000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65396000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	217991000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	360000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	31670000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	171882000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	171522000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	186321000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3500000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	360000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	397000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200360000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	374000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	389000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1855000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	203735000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-103855000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-171264000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-395912000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11855000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	74000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	34000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-31000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	37000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-561000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	68000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-204000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-230000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	635000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	113000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	11000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-173000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4355000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15425000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-82000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-930000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	5709000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-21810000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-35965000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-83141000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5167000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5494000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-21717000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	10303000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4696000	USD
CY2020	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensation	728000	USD
CY2019	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensation	595000	USD
CY2018	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensation	294000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	273000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	524000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1772000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	185000	USD
CY2020	pgen	Effective Income Tax Rate Reconciliation Acquisitionrelated Transaction Costs EffectiveIncomeTaxRateReconciliationAcquisitionrelatedTransactionCosts	0	USD
CY2019	pgen	Effective Income Tax Rate Reconciliation Acquisitionrelated Transaction Costs EffectiveIncomeTaxRateReconciliationAcquisitionrelatedTransactionCosts	260000	USD
CY2018	pgen	Effective Income Tax Rate Reconciliation Acquisitionrelated Transaction Costs EffectiveIncomeTaxRateReconciliationAcquisitionrelatedTransactionCosts	52000	USD
CY2020	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Reacquired Inprocess Researchand Development Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseReacquiredInprocessResearchandDevelopmentAmount	0	USD
CY2019	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Reacquired Inprocess Researchand Development Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseReacquiredInprocessResearchandDevelopmentAmount	0	USD
CY2018	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Reacquired Inprocess Researchand Development Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseReacquiredInprocessResearchandDevelopmentAmount	2696000	USD
CY2020	pgen	Effective Income Tax Rate Reconciliation Changein Deferred State Tax Rate Amount EffectiveIncomeTaxRateReconciliationChangeinDeferredStateTaxRateAmount	0	USD
CY2019	pgen	Effective Income Tax Rate Reconciliation Changein Deferred State Tax Rate Amount EffectiveIncomeTaxRateReconciliationChangeinDeferredStateTaxRateAmount	0	USD
CY2018	pgen	Effective Income Tax Rate Reconciliation Changein Deferred State Tax Rate Amount EffectiveIncomeTaxRateReconciliationChangeinDeferredStateTaxRateAmount	8666000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-21000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-76000	USD
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	215000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-306000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-72000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3517000	USD
CY2020	pgen	Income Tax Reconciliation Income Tax Expense Benefit Before Valuation Allowance IncomeTaxReconciliationIncomeTaxExpenseBenefitBeforeValuationAllowance	-21391000	USD
CY2019	pgen	Income Tax Reconciliation Income Tax Expense Benefit Before Valuation Allowance IncomeTaxReconciliationIncomeTaxExpenseBenefitBeforeValuationAllowance	-31948000	USD
CY2018	pgen	Income Tax Reconciliation Income Tax Expense Benefit Before Valuation Allowance IncomeTaxReconciliationIncomeTaxExpenseBenefitBeforeValuationAllowance	-91941000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	21309000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	31018000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	76516000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-82000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-930000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15425000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1816000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2140000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	289000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	415000	USD
CY2020Q4	pgen	Deferred Tax Asset Equity Method Investmentsand Investments Accounted For Under The Fair Value Option DeferredTaxAssetEquityMethodInvestmentsandInvestmentsAccountedForUnderTheFairValueOption	570000	USD
CY2019Q4	pgen	Deferred Tax Asset Equity Method Investmentsand Investments Accounted For Under The Fair Value Option DeferredTaxAssetEquityMethodInvestmentsandInvestmentsAccountedForUnderTheFairValueOption	11933000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1882000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1830000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	74981000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	85308000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1834000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3385000	USD
CY2020Q4	pgen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	6140000	USD
CY2019Q4	pgen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	10035000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	16402000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	19389000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7423000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	14876000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	10210000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	9686000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	8592000	USD
CY2020Q4	pgen	Deferred Tax Assets Operating Capital Loss And Interest Expense Carryforwards DeferredTaxAssetsOperatingCapitalLossAndInterestExpenseCarryforwards	275519000	USD
CY2019Q4	pgen	Deferred Tax Assets Operating Capital Loss And Interest Expense Carryforwards DeferredTaxAssetsOperatingCapitalLossAndInterestExpenseCarryforwards	196663000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	82374000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2834000	USD
CY2020Q4	pgen	Deferred Tax Liabilities Equity Componentof Long Term Debt DeferredTaxLiabilitiesEquityComponentofLongTermDebt	7604000	USD
CY2019Q4	pgen	Deferred Tax Liabilities Equity Componentof Long Term Debt DeferredTaxLiabilitiesEquityComponentofLongTermDebt	9987000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	349008000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	397066000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	364252000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	387348000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	349008000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9718000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	15244000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5011000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	8091000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	12615000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18078000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2897000	USD
CY2018	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations Treated As Asset Sales ValuationAllowanceDeferredTaxAssetsDiscontinuedOperationsTreatedAsAssetSales	3832000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	292217000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	211078000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Mergers And Acquisitions Net ValuationAllowanceDeferredTaxAssetChangeInAmountMergersAndAcquisitionsNet	0	USD
CY2019	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Mergers And Acquisitions Net ValuationAllowanceDeferredTaxAssetChangeInAmountMergersAndAcquisitionsNet	0	USD
CY2018	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Mergers And Acquisitions Net ValuationAllowanceDeferredTaxAssetChangeInAmountMergersAndAcquisitionsNet	418000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Asset Deconsolidation ValuationAllowanceDeferredTaxAssetDeconsolidation	0	USD
CY2019	pgen	Valuation Allowance Deferred Tax Asset Deconsolidation ValuationAllowanceDeferredTaxAssetDeconsolidation	-3504000	USD
CY2018	pgen	Valuation Allowance Deferred Tax Asset Deconsolidation ValuationAllowanceDeferredTaxAssetDeconsolidation	0	USD
CY2020	pgen	Valuation Allowance Deferred Tax Assets Establishment Of Deferred Taxes For Subsidiaries Included In Discontinued Operations ValuationAllowanceDeferredTaxAssetsEstablishmentOfDeferredTaxesForSubsidiariesIncludedInDiscontinuedOperations	0	USD
CY2019	pgen	Valuation Allowance Deferred Tax Assets Establishment Of Deferred Taxes For Subsidiaries Included In Discontinued Operations ValuationAllowanceDeferredTaxAssetsEstablishmentOfDeferredTaxesForSubsidiariesIncludedInDiscontinuedOperations	8592000	USD
CY2018	pgen	Valuation Allowance Deferred Tax Assets Establishment Of Deferred Taxes For Subsidiaries Included In Discontinued Operations ValuationAllowanceDeferredTaxAssetsEstablishmentOfDeferredTaxesForSubsidiariesIncludedInDiscontinuedOperations	0	USD
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Current Year Operations ValuationAllowanceDeferredTaxAssetChangeInAmountCurrentYearOperations	21309000	USD
CY2019	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Current Year Operations ValuationAllowanceDeferredTaxAssetChangeInAmountCurrentYearOperations	31018000	USD
CY2018	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Current Year Operations ValuationAllowanceDeferredTaxAssetChangeInAmountCurrentYearOperations	98549000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations Treated As Asset Sales ValuationAllowanceDeferredTaxAssetsDiscontinuedOperationsTreatedAsAssetSales	7977000	USD
CY2019	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations Treated As Asset Sales ValuationAllowanceDeferredTaxAssetsDiscontinuedOperationsTreatedAsAssetSales	10585000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations ValuationAllowanceDeferredTaxAssetsDiscontinuedOperations	8019000	USD
CY2019	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations ValuationAllowanceDeferredTaxAssetsDiscontinuedOperations	9663000	USD
CY2018	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations ValuationAllowanceDeferredTaxAssetsDiscontinuedOperations	8735000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Equity Componentof Long Term Debt ValuationAllowanceDeferredTaxAssetChangeInEquityComponentofLongTermDebt	0	USD
CY2019	pgen	Valuation Allowance Deferred Tax Asset Change In Equity Componentof Long Term Debt ValuationAllowanceDeferredTaxAssetChangeInEquityComponentofLongTermDebt	0	USD
CY2018	pgen	Valuation Allowance Deferred Tax Asset Change In Equity Componentof Long Term Debt ValuationAllowanceDeferredTaxAssetChangeInEquityComponentofLongTermDebt	-13367000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Deferred State Tax Rate ValuationAllowanceDeferredTaxAssetChangeInDeferredStateTaxRate	0	USD
CY2019	pgen	Valuation Allowance Deferred Tax Asset Change In Deferred State Tax Rate ValuationAllowanceDeferredTaxAssetChangeInDeferredStateTaxRate	0	USD
CY2018	pgen	Valuation Allowance Deferred Tax Asset Change In Deferred State Tax Rate ValuationAllowanceDeferredTaxAssetChangeInDeferredStateTaxRate	-8666000	USD
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Foreign Currency Translation Adjustment ValuationAllowanceDeferredTaxAssetChangeInForeignCurrencyTranslationAdjustment	1035000	USD
CY2019	pgen	Valuation Allowance Deferred Tax Asset Change In Foreign Currency Translation Adjustment ValuationAllowanceDeferredTaxAssetChangeInForeignCurrencyTranslationAdjustment	-75000	USD
CY2018	pgen	Valuation Allowance Deferred Tax Asset Change In Foreign Currency Translation Adjustment ValuationAllowanceDeferredTaxAssetChangeInForeignCurrencyTranslationAdjustment	-885000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	387348000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	349008000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	292217000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6900000	shares
CY2018Q1	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3688000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	188000	USD
CY2018Q3	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	7479431	shares
CY2018Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	13.37
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18366000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18950000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36296000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward	ten
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2042000	USD
CY2020	pgen	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	3578000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	3821000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1763000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	842000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	845000	USD
CY2020	us-gaap	Lease Cost LeaseCost	6183000	USD
CY2019	us-gaap	Lease Cost LeaseCost	6708000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-66748000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12911000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3608000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3392000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2087000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1841000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1116000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	867000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2510000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10401000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2657000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7744000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10401000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M15D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M21D
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-134219000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-170521000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1027
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1032
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	4012000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	3877000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	417000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1137000	USD
CY2020Q4	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	3	claim
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-103773000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-168742000	USD
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-375117000	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-153582000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-322324000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-509336000	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	167065539	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	154138774	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	129521731	shares
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.62
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-1.09
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-2.90
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.40
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-1.00
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-1.03
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.02
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.09
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.93
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-171264000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24849312	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32260596	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31152336	shares
CY2020	pgen	Net Income Loss Attributableto Parent Adjusted Ebitda Including Cash Paidfor Capital Expendituresand Investmentsin Affiliates NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates	-28713000	USD
CY2019	pgen	Net Income Loss Attributableto Parent Adjusted Ebitda Including Cash Paidfor Capital Expendituresand Investmentsin Affiliates NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates	-56115000	USD
CY2018	pgen	Net Income Loss Attributableto Parent Adjusted Ebitda Including Cash Paidfor Capital Expendituresand Investmentsin Affiliates NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates	-62067000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103178000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90722000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151178000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-103855000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-395912000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29838000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30424000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23583000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19333000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16600000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11830000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-23006000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-35167000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-20846000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-15709000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-27536000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-39682000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-55998000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-43354000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-29508000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-41661000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.13
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.10
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.17
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.22
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22585000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32836000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18299000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17002000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-41855000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-21508000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-34702000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.14
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.25
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-68724000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-44539000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-22440000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-39119000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-64236000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-60709000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-38766000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-53634000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-169215000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.28
CY2019Q4	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.41
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.09
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	873000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1186000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1392000	USD

Files In Submission

Name	View Source	Status
0001356090-21-000003-index-headers.html	Edgar Link	pending
0001356090-21-000003-index.html	Edgar Link	pending
0001356090-21-000003.txt	Edgar Link	pending
0001356090-21-000003-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pgen-20201231.htm	Edgar Link	pending
pgen-20201231.xsd	Edgar Link	pending
pgen-20201231xexx211.htm	Edgar Link	pending
pgen-20201231xexx231.htm	Edgar Link	pending
pgen-20201231xexx232.htm	Edgar Link	pending
pgen-20201231xexx311.htm	Edgar Link	pending
pgen-20201231xexx312.htm	Edgar Link	pending
pgen-20201231xexx321.htm	Edgar Link	pending
pgen-20201231xexx322.htm	Edgar Link	pending
pgen-20201231_cal.xml	Edgar Link	unprocessable
pgen-20201231_def.xml	Edgar Link	unprocessable
pgen-20201231_g1.jpg	Edgar Link	pending
pgen-20201231_g10.jpg	Edgar Link	pending
pgen-20201231_g11.jpg	Edgar Link	pending
pgen-20201231_g12.jpg	Edgar Link	pending
pgen-20201231_g13.jpg	Edgar Link	pending
pgen-20201231_g14.jpg	Edgar Link	pending
pgen-20201231_g15.jpg	Edgar Link	pending
pgen-20201231_g16.jpg	Edgar Link	pending
pgen-20201231_g17.jpg	Edgar Link	pending
pgen-20201231_g18.jpg	Edgar Link	pending
pgen-20201231_g2.jpg	Edgar Link	pending
pgen-20201231_g3.jpg	Edgar Link	pending
pgen-20201231_g4.jpg	Edgar Link	pending
pgen-20201231_g5.jpg	Edgar Link	pending
pgen-20201231_g6.jpg	Edgar Link	pending
pgen-20201231_g7.jpg	Edgar Link	pending
pgen-20201231_g8.jpg	Edgar Link	pending
pgen-20201231_g9.jpg	Edgar Link	pending
pgen-20201231_htm.xml	Edgar Link	completed
pgen-20201231_lab.xml	Edgar Link	unprocessable
pgen-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PGEN
PRECIGEN, INC. Stock $pgen

2020 Q4 Form 10-K Financial Statement

#000135609021000003 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN PRECIGEN, INC. Stock $pgen

2020 Q4 Form 10-K Financial Statement

#000135609021000003 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN
PRECIGEN, INC. Stock $pgen